Public preview. Funding rounds, founders, and growth signals require a free account.

Can-Fite BioPharma Ltd. (CANF)

Israeli biopharmaceutical company developing A3AR-targeted drugs for cancer, liver, and inflammatory diseases in Phase II/III trials.

GrowthPharmaPetach Tikva, L3

Total raised

$82.2M

Last round

Option

$10.0M · Dec 2021

Stage

Growth

Status

Active

Founders & team

Co-founder, CEO

Co-founder, CTO

Head of Engineering

Head of Sales

🔒

Free account unlocks founder names, LinkedIn profiles, and prior companies.

Web traffic

Search interest

Social followers

Glassdoor rating

News mentions

Gov contracts

🔒

Free account unlocks 5 full profiles per day. Pro removes the limit.

Get notified the moment Can-Fite BioPharma Ltd. (CANF) files a new round, hires execs, or shows traction signals.

About this data

FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.